Dean Glettig
Dean Glettig is Senior Director of Product Development at Finch Therapeutics. Dean has been a lead in development and scale-up of all products since he started at Finch in 2016 and was the CMC lead on the partnership program with Takeda. Prior to joining Finch, he worked in the Langer Lab at MIT, where he developed novel oral drug delivery technologies. This resulted in the filing of 4 patents and the start of a spin-off company.
Dean received his BSc & MSc in Chemistry from ETH Zurich and a PhD in Biomedical Engineering from Tufts University.
Aarti Kapoor
Aarti Kapoor is a Partner at VMG Partners, a growth equity investment firm focused on partnering with high-growth consumer and retail companies, and brings 18 years of experience in high-growth consumer and retail across principal investing and M&A / capital markets advisory. Kapoor was formerly CEO of VMG-affiliated special purpose acquisition company, VMG Consumer Acquisition Corp. (NASDAQ:VMGA), from June 2021 to May 2023. Prior to joining VMG Partners, Kapoor was an investment banker at Goldman Sachs where she was integral to the disruptive growth effort within consumer and retail investment banking, growing the firm’s coverage of leisure, lifestyle, and wellness brands. Prior to joining Goldman Sachs, she was an investment banker at Moelis & Company where she built one of Wall Street’s first coverage platforms focused on the health and wellness industry. Aarti has been recognized for her work in consumer and retail dealmaking by various publications, listed to "Forbes 30 Under 30" in Finance and Business Insider's "Rising Stars" of Wall Street, and featured in Bloomberg, CNBC, Yahoo! Finance and more. Aarti is based in New York, NY.
Vincent Miceli
Vincent (Vin) Miceli, founded Verb in 2018 and has served as the CEO since its inception. He defined the vision and strategy and is leading the company through multiple phases of rapid growth.
Verb is an AI accountability partner and life coach in one. Verb focuses on improving daily habits in small increments, as a method to addressing overall wellness. With stints on Wall Street, Vin is a dedicated serial entrepreneur and the founder and owner for Body Blueprint Gym. He earned his BA degree in Business and Finance from Sacred Heart University.
Trent Ward
Scott Marcaccio
Scott Marcaccio is the Co-Founder and Chief Executive Officer of Myodetox, an omnichannel physical therapy brand operating 13 locations across Los Angeles, Vancouver, and Toronto. With a mission to heal the world, the Myodetox team envisions a future where everyone has the tools, knowledge, and professional guidance to take care of their bodies, and nobody has to live with pain.
Meridith Cass
Meridith is the Founder and CEO of Nix, a consumer health data startup, spun out of Harvard. The initial product is a sweat sensor that informs athletes, soldiers, and laborers of their fluid losses, electrolyte losses, and sweat composition in real-time. The platform also generates personalized predictive data for fluid and electrolyte needs.
A serial company starter, Meridith has worked closely with several Boston and New York-based venture capital firms in the creation of seven life science and consumer startups prior to Nix. Meridith sits on the board of several companies and non-profits including Girls on the Run of Greater Boston, Consumer Technology Association’s Health and Fitness Technology Division, and the Cambridge Friends School, of which she is an alumna.
Meridith is a college basketball player-turned-marathoner who has completed 9 marathons, including the all of the World Major Marathons. She received her A.B. from Bryn Mawr College where she received the Anna Pell Wheeler Prize for Mathematics, and her M.B.A. from Harvard Business School. Meridith is a Kauffman Fellow as well as a Harvard Business School Blavatnik Fellow.